Better Therapeutics Stock Total Debt
Better Therapeutics fundamentals help investors to digest information that contributes to Better Therapeutics' financial success or failures. It also enables traders to predict the movement of Better OTC Stock. The fundamental analysis module provides a way to measure Better Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Better Therapeutics otc stock.
Better |
Better Therapeutics OTC Stock Total Debt Analysis
Better Therapeutics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Better Therapeutics Total Debt | 14.88 M |
Most of Better Therapeutics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Better Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Better Therapeutics has a Total Debt of 14.88 M. This is 99.46% lower than that of the Biotechnology sector and 95.42% lower than that of the Health Care industry. The total debt for all United States stocks is 99.72% higher than that of the company.
Better Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Better Therapeutics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Better Therapeutics could also be used in its relative valuation, which is a method of valuing Better Therapeutics by comparing valuation metrics of similar companies.Better Therapeutics is currently under evaluation in total debt category among its peers.
Better Fundamentals
| Return On Equity | -10.22 | |||
| Return On Asset | -0.95 | |||
| Current Valuation | 8.83 M | |||
| Shares Outstanding | 54.52 M | |||
| Shares Owned By Insiders | 53.41 % | |||
| Shares Owned By Institutions | 2.94 % | |||
| Number Of Shares Shorted | 2.13 M | |||
| Price To Book | 2.29 X | |||
| Price To Sales | 49,559 X | |||
| Gross Profit | (674 K) | |||
| EBITDA | (29.18 M) | |||
| Net Income | (31.57 M) | |||
| Cash And Equivalents | 29.68 M | |||
| Cash Per Share | 1.25 X | |||
| Total Debt | 14.88 M | |||
| Debt To Equity | 0.81 % | |||
| Current Ratio | 5.23 X | |||
| Book Value Per Share | (0.24) X | |||
| Cash Flow From Operations | (26.08 M) | |||
| Short Ratio | 0.94 X | |||
| Earnings Per Share | (1.10) X | |||
| Target Price | 5.25 | |||
| Number Of Employees | 54 | |||
| Beta | 2.35 | |||
| Market Capitalization | 1.12 M | |||
| Total Asset | 22.94 M | |||
| Retained Earnings | (111.5 M) | |||
| Working Capital | 4.95 M | |||
| Z Score | -10.7 | |||
| Net Asset | 22.94 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Better OTC Stock
If you are still planning to invest in Better Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Better Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |